1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 11-20 of 29 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Transition of care in inflammatory bowel disease: mind the gap! Theory, practice and recommendations for an Australian contextBryant, R.; Trott, M.; Bennett, A.; Bampton, P.; Moore, D.; Andrews, J.
2015Effect of intestinal resection on quality of life in Crohn's diseaseWright, E.; Kamm, M.; De Cruz, P.; Hamilton, A.; Ritchie, K.; Krejany, E.; Gorelik, A.; Liew, D.; Prideaux, L.; Lawrance, I.; Andrews, J.; Bampton, P.; Sparrow, M.; Florin, T.; Gibson, P.; Debinski, H.; Gearry, R.; Macrae, F.; Leong, R.; Kronborg, I.; et al.
2015Doctor communication quality and friends' attitudes influence complementary medicine use in inflammatory bowel diseaseMountifield, R.; Andrews, J.; Mikocka-Walus, A.; Bampton, P.
2015Compassionate access anti-tumour necrosis factor-α therapy for ulcerative colitis in Australia: the benefits to patientsCostello, S.; Ghaly, S.; Beswick, L.; Pudipeddi, A.; Agarwal, A.; Sechi, A.; O'Connor, S.; Connor, S.; Sparrow, M.; Bampton, P.; Walsh, A.; Andrews, J.
2010Pregnancy and IBD treatment: This challenging interplay from a patients' perspectiveMountifield, R.; Prosser, R.; Bampton, P.; Muller, K.; Andrews, J.
2010Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: An Australian and New Zealand experienceLawrance, I.; Radford-Smith, G.; Bampton, P.; Andrews, J.; Tan, P.; Croft, A.; Gearry, R.; Florin, T.
2013Thiopurine metabolite measurement leads to changes in management of inflammatory bowel diseaseKennedy, N.; Asser, T.; Mountifield, R.; Doogue, M.; Andrews, J.; Bampton, P.
2010Un-promoted Issues in Inflammatory Bowel Disease (IBD): Opportunities to Optimise CareAndrews, J.; Mountifield, R.; Van Langenberg, D.; Bampton, P.; Holtmann, G.
2014Immune derived opioidergic inhibition of viscerosensory afferents is decreased in Irritable Bowel Syndrome patientsHughes, P.; Moretta, M.; Lim, A.; Grasby, D.; Bird, D.; Brierley, S.; Liebregts, T.; Adam, B.; Ashley Blackshaw, L.; Holtmann, G.; Bampton, P.; Hoffmann, P.; Andrews, J.; Zola, H.; Krumbiegel, D.
2014Covert dose reduction is a distinct type of medication non-adherence observed across all care settings in Inflammatory Bowel DiseaseMountifield, R.; Andrews, J.; Mikocka-Walus, A.; Bampton, P.

Discover